Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation (Q36734197)
Jump to navigation
Jump to search
scientific article published on 4 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation |
scientific article published on 4 March 2016 |
Statements
1 reference
Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation (English)
1 reference
Shunichiro Iwasawa
Takahiro Ebata
Tsukasa Ishiwata
Ikuo Sekine
Yuji Tada
Koichiro Tatsumi
Shuhei Koide
4 March 2016
1 reference
1 reference
1 reference
1 reference